The Medicines Co. Sues Over Missed FDA Deadline on Angiomax

Although it ultimately prevailed, The Medicines Company recently sued successor firms who had represented it during the process of seeking an FDA extension on angiomax, a drug I’ve heard of and so which must be important.  A story (hopefully not behind a paywall) is here.

About David

Professor of Law, Mercer University School of Law. Of Counsel, Taylor English Duma, LLP. Former judicial clerk to Chief Judge Rader; former lawyer with Baker Botts and other firms